Market Overview

Left Long Valeant: A Technical Look


Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares are trading higher by $1.15 at $27.05. The issue is getting a lift off the announcement that Andrew Left of Citron Research is long the issue.

Left was the one of the first to call out the issue as a short and is now trying it find from the long side.

Related Link: Valeant Spikes After Andrew Left Says He's Long The Stock, Out-Of-Money Puts

The issue reached its lowest level since November 2010 last week when it bottomed at $23.55. It rebounded to end the week at $25.90.

The news of Left's stake has for the moment pushed the issue beyond the pair of highs from Thursday ($26.67) and Friday ($26.60), jumping into the $27 handle, with $27.15 standing as the current high.

Posted-In: Andrew Left Citron ResearchShort Sellers Technicals Intraday Update Movers Trading Ideas


Related Articles (VRX)

View Comments and Join the Discussion!

An ETF That Takes Investors To Dividend Growth

Leon Cooperman Buys 227,000 Apple Shares, Adds More Microsoft